Wall Street Zen Upgrades Rapid Micro Biosystems (NASDAQ:RPID) to Hold

Rapid Micro Biosystems (NASDAQ:RPID) was upgraded by equities research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report issued on Monday.

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Rapid Micro Biosystems in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Rapid Micro Biosystems presently has an average rating of “Moderate Buy” and an average price target of $8.00.

Rapid Micro Biosystems Trading Up 10.5%

Shares of RPID stock opened at $3.38 on Monday. The business has a 50-day moving average price of $3.54 and a two-hundred day moving average price of $3.32. Rapid Micro Biosystems has a 12-month low of $0.98 and a 12-month high of $4.50. The company has a quick ratio of 2.95, a current ratio of 4.23 and a debt-to-equity ratio of 0.42. The firm has a market cap of $149.80 million, a P/E ratio of -3.35 and a beta of 1.36.

Rapid Micro Biosystems (NASDAQ:RPID) last announced its quarterly earnings data on Friday, November 7th. The company reported ($0.26) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.26). The company had revenue of $7.84 million for the quarter, compared to analysts’ expectations of $7.60 million. Rapid Micro Biosystems had a negative return on equity of 73.90% and a negative net margin of 145.11%. Equities analysts anticipate that Rapid Micro Biosystems will post -1.1 EPS for the current fiscal year.

Institutional Trading of Rapid Micro Biosystems

A number of institutional investors have recently modified their holdings of the company. Geode Capital Management LLC increased its holdings in Rapid Micro Biosystems by 1.6% during the 2nd quarter. Geode Capital Management LLC now owns 204,079 shares of the company’s stock valued at $704,000 after purchasing an additional 3,143 shares during the period. American Century Companies Inc. grew its position in shares of Rapid Micro Biosystems by 46.1% in the 2nd quarter. American Century Companies Inc. now owns 16,922 shares of the company’s stock worth $58,000 after buying an additional 5,341 shares during the last quarter. Susquehanna International Group LLP increased its stake in shares of Rapid Micro Biosystems by 12.6% during the third quarter. Susquehanna International Group LLP now owns 58,387 shares of the company’s stock valued at $195,000 after buying an additional 6,528 shares during the period. Hudson Bay Capital Management LP bought a new position in shares of Rapid Micro Biosystems during the third quarter valued at approximately $38,000. Finally, Dimensional Fund Advisors LP raised its holdings in shares of Rapid Micro Biosystems by 37.8% during the third quarter. Dimensional Fund Advisors LP now owns 55,642 shares of the company’s stock valued at $186,000 after acquiring an additional 15,255 shares in the last quarter. 52.60% of the stock is currently owned by hedge funds and other institutional investors.

About Rapid Micro Biosystems

Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.

In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.